Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06861504 · ClinicalTrials.gov registry record · NA

The Femscope Calm Collect Device

A NA study of Cervical Cancer, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
13
Enrollment target
1
Study location

NCT06861504 is a NA study of Cervical Cancer that has completed, run by University of Michigan. The registered enrollment target is 13 participants, below the 570-participant average among 144 other Cervical Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06861504, a NA study of Cervical Cancer, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to determine if cervical cells collected by the Femscope Calm Collect Device in women (sex assigned at birth) of adult age are the same quality and quantity as the cervical cells collected by the traditional brush method for cervical cancer screening. The main questions it aims to answer are: 1. Increase the number of women who get screened for cervical cancer. 2. Improve patient acceptance of getting cervical screening on a routine basis. 3. Decrease pain and discomfort for patients having a PAP smear procedure. Participants will * Have two vaginal exams to collect cervical cells. * State decreased pain and discomfort for patients having a PAP smear procedure. * The Femscope Calm Collect Device (FCCD) will be more comfortable for the patient as measured by a patient satisfaction survey comparing the FCCD and the traditional speculum method of obtaining cervical cells.

Conditions Studied

Interventions

  • DEVICE Femscope Calm Collect Device

Study Locations (1)

Michigan

  • University of Michigan Flint - Flint

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2024-12-12
Est. Completion 2025-08-28
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT06861504

The ClinicalTrials.gov registry entry for NCT06861504 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 570-participant average among 144 other Cervical Cancer trials with a reported enrollment target (98% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cervical Cancer appearing as the primary indexed condition, and to 1 intervention - of which Femscope Calm Collect Device is the first listed.

NCT06861504 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT06861504 about?

NCT06861504 is a clinical study titled "The Femscope Calm Collect Device". The goal of this clinical trial is to determine if cervical cells collected by the Femscope Calm Collect Device in women (sex assigned at birth) of adult age are the same quality and quantity as the cervical cells collected by the traditional brush method for cervical cancer screening. The main ques...

What is the current status of trial NCT06861504?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2024-12-12. Estimated completion is 2025-08-28.

What conditions does trial NCT06861504 study?

This clinical trial studies the following conditions: Cervical Cancer.

What interventions are being tested in trial NCT06861504?

The interventions under investigation include: Femscope Calm Collect Device (DEVICE).

Who is sponsoring clinical trial NCT06861504?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06861504 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cervical Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.